himbacine analogs (Kyorin)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namehimbacine analogs (Kyorin)
Drug Alias Name3-demethylhimbacine3-norhimbacinemuscarinic M2 antagonists (Kyorin)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M2 antagonists
TargetsMuscarinic acetylcholine receptor M2
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyorin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyorin Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A